🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine the safety, tolerability, and phar...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT06570434
Treatments Being Tested
The main objective is to assess the safety and tolerability of subcutaneous...
Status
Completed
Location
Nucleus Network Brisbane
Start Date
2025-08-11
Trial ID
NCT07090655
Treatments Being Tested
The main objective is to assess the safety and tolerability of budoprutug i...
Status
Recruiting
Location
Climb Bio Investigative Site #100104
Start Date
2025-07-10
Trial ID
NCT07011043
Treatments Being Tested
The main objective is to assess the safety and tolerability of budoprutug i...
Status
Recruiting
Location
Climb Bio Investigative Site #359202
Start Date
2025-06-30
Trial ID
NCT07043946
Treatments Being Tested
To evaluate the safety and tolerability of three dose regimens of budoprutu...
Status
Recruiting
Location
Climb Bio Investigative Site #110
Start Date
2025-08-25
Trial ID
NCT07096843
Treatments Being Tested
Budoprutug is a humanized, immunoglobulin (Ig) G1 monoclonal antibody that ...
Status
Recruiting
Location
Mianyang Central Hospital
Start Date
2026-06-30
Trial ID
NCT07564596
Treatments Being Tested